Founded
Address
Burrill & Co LLC
One Embarcadero Center
Suite 2700
San Francisco, CA 94111
United States
Phone
Website
Recent investment activity
KANDO id: 2488
Company type
Diversified global financial services firm focused on the life sciences industryFunds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Burrill Life Sciences Capital Fund IV | 2011 | USD | 500,000,000 |
Funding rounds
Investment preferences
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 33| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Strand Life Sciences Pvt Ltd | Series B | ||||
|
|
Ceptaris Therapeutics Inc | Specialty pharmaceuticals company. | Series D | |||
|
WaveTec Vision Systems Inc | Venture Initial investment | ||||
|
|
Endocyte Inc | Folate-based cancer and autoimmune disease therapies | Series C | |||
|
|
Aerovance Inc | N/A | ||||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series C | |||
|
|
Arete Therapeutics Inc | A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. | Series A | |||
|
|
Osprey Pharmaceuticals USA | Series A | ||||
|
|
Light Sciences Oncology Inc | Drug-device cancer therapy | Series B | |||
|
|
Aerovance Inc | Series C | ||||
|
diaDexus Inc | Biotechnology company focused on the discovery, development & commercialization of novel, patent protected diagnostic product with high clinical value | Series E | |||
|
|
Neurotech Pharmaceuticals Inc (Neurotech Inc) | Cell-based drugs for diseases of the eye. | Series B | |||
|
|
Sciona Inc | Provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. | Series C | |||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series B | |||
|
|
XDx Inc | N/A Initial investment | ||||
|
|
Adlyfe | Series A | ||||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series A | |||
|
|
Sciona Inc | Provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. | Series B | |||
|
|
Logical Therapeutics Inc | An early stage biotechnology company | N/A | |||
|
|
Immunicon Corp | Biotechnology company specializing in cell-based research and diagnostic products with an initial focus on cancer. | N/A | |||
|
|
elbion AG | N/A | ||||
|
|
Whiteglove House Call Health Inc | N/A | ||||
|
|
Inhibitex Inc | N/A | ||||
|
AgraQuest Inc | Discovery, development, manufacturing and marketing of biopesticides and low-chem pest and disease control, and yield enhancing products. | N/A | |||
|
|
ProteoGenix Inc | N/A |
Current team
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Dr John E Hamer | Golden Pine Ventures LLC |